Dudediligence.

Bolt Biotherapeutics, Inc

BOLTNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.1MSep ’24$0.00Dec ’24$1.2MMar ’25$1.8MJun ’25$2.2MSep ’25$2.5MDec ’25$26,000Mar ’26$5,000Jun ’26
Net income, by quarter
−$15.2MSep ’24−$15.9MDec ’24−$11.0MMar ’25−$8.6MJun ’25−$7.1MSep ’25−$6.6MDec ’25−$7.2MMar ’26−$7.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.3M$5.7M$7.9M$7.7M$7.7M
Operating income−$92.8M−$90.3M−$76.2M−$73.0M−$36.1M
Net income−$98.6M−$88.1M−$69.2M−$63.1M−$33.4M
Operating cash flow−$57.1M−$76.5M−$69.5M−$61.3M−$39.9M
Free cash flow−$59.4M−$78.5M−$69.7M−$61.3M−$39.9M
Cash$27.4M$9.2M$10.8M$7.2M$11.7M
Shares outstanding37.4M37.8M38.1M1.9M1.9M